Cargando…
P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429580/ http://dx.doi.org/10.1097/01.HS9.0000848664.50083.13 |
| _version_ | 1784779499931435008 |
|---|---|
| author | Hao, M. Yin, D. Li, Y. Gi, Y. Tian, J. Guo, H. Fan, D. Qin, W. Liu, Q. Wang, W. Li, L. Peng, Z. Liu, L. |
| author_facet | Hao, M. Yin, D. Li, Y. Gi, Y. Tian, J. Guo, H. Fan, D. Qin, W. Liu, Q. Wang, W. Li, L. Peng, Z. Liu, L. |
| author_sort | Hao, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429580 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295802022-08-31 P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS Hao, M. Yin, D. Li, Y. Gi, Y. Tian, J. Guo, H. Fan, D. Qin, W. Liu, Q. Wang, W. Li, L. Peng, Z. Liu, L. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429580/ http://dx.doi.org/10.1097/01.HS9.0000848664.50083.13 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Hao, M. Yin, D. Li, Y. Gi, Y. Tian, J. Guo, H. Fan, D. Qin, W. Liu, Q. Wang, W. Li, L. Peng, Z. Liu, L. P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS |
| title | P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS |
| title_full | P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS |
| title_fullStr | P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS |
| title_full_unstemmed | P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS |
| title_short | P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS |
| title_sort | p1452: the preliminary safety and efficacy study of sc-u02, a non-viral genome targeting, anti-cd19 universal car-t product, in relapsed/refractory (r/r) diffuse large b-cell lymphoma patients |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429580/ http://dx.doi.org/10.1097/01.HS9.0000848664.50083.13 |
| work_keys_str_mv | AT haom p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT yind p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT liy p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT giy p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT tianj p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT guoh p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT fand p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT qinw p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT liuq p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT wangw p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT lil p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT pengz p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients AT liul p1452thepreliminarysafetyandefficacystudyofscu02anonviralgenometargetinganticd19universalcartproductinrelapsedrefractoryrrdiffuselargebcelllymphomapatients |